Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Leona M. and Harry B. Helmsley Charitable Trust | OTHER |
Not provided
Not provided
Not provided
Not provided
One of the major obstacles in implementing intestinal ultrasound services for inflammatory bowel disease (IBD) patients relates to the costs of acquiring ultrasound (US) machines. The costs of high-end (and higher levels of quality) US machines are considerable, and although large medical centers in developed countries can obtain US machines, smaller centers in rural areas, community centers and centers in undeveloped countries may struggle with the cost of the machines. The lack of availability of point-of-care intestinal ultrasound impedes the medical treatment IBD patients receive. Recently, new models of hand-held small ultrasound machines were introduced to the market by large ultrasound companies. These machines are affordable and are used mainly for point-of-care ultrasound exams. We hypothesize that if the image quality acquired by these machines is proven to be good enough for the detection of bowel inflammation and complications in Crohn's disease (CD) patients, the use of intestinal ultrasound can potentially increase, allowing better care for CD patients.
Our idea is to compare the accuracy of various hand-held ultrasound devices to detect ultrasonographic signs of bowel inflammatory activity (especially increased bowel wall thickness) to that of high-end and premium US machines. The first part of the project will include examining the quality of 2 different hand-held US machines (GE VSCAN air and Philips Lumify) by 3 experienced ultra-sonographers. If the achieved level of accuracy for the detection of bowel wall inflammatory activity will be sufficient (AUC>0.8), we aim to move to the second part of the project. This step focuses on hand-held US machines by gastroenterologists with various levels of IUS experience. Therefore, we aim to examine the accuracy of hand-held US machines for the detection of inflammatory activity by delivering the hand-held US machines to 10 GI specialists who completed the IBUS educational curriculum for IUS (at least module 1+2) with various levels of IUS expertise.
Significance/Impact The use of affordable and precise US machines will disseminate the use of IUS and expand the IUS incorporation into the diagnosis, monitoring, and treatment of CD, improving patient outcomes
• Aim 1. Comparison of the accuracy of hand-held US machines for the detection and measurement of bowel wall inflammatory activity to that of advanced high-end and premium US machines by experienced IUS performers
Other signs of inflammation will also be examined: Doppler signs within the bowel wall using the modified Limberg scoring system, mesenteric fat hypertrophy, stratification of bowel wall layers and enlargement of lymph nodes.
Intramural and extramural complications including strictures with\without pre-stenotic dilatations, fistulas, and abscesses will be noted and the relative images will be saved.
The findings of different signs of inflammation described will be compared between the hand-held ultrasound and the high-end \ premium US machines. A dichotomic comparison for the presence of each sign (yes/no) will be followed by a comparison of numerical parameters (exact bowel thickness measurement for each segment and Limberg score).
The saved images and cine loops of each segment will be reviewed blindly by one of the other sonographers and assessed for inter-reader agreement between different performers.
An ICC analysis will be performed for the primary outcome of bowel wall thickness.
Expected Outcomes/Results: To define if the hand-held US machine can detect basic ultrasonographic signs of inflammation (bowel wall thickness) with adequate accuracy compared with gold-standard high-end \ premium US machines.
• Aim 2: Comparison of the accuracy of hand-held US machines for the detection and measurement of bowel wall inflammatory activity to that of advanced high-end and premium US machines by ultra-sonographers with ultra-sonographers with various experience levels.
Rationale: Judging from preliminary experience, we hypothesize hand-held US machines will be accurate for the detection of inflammatory activity when used by experienced IUS performers. However, the accuracy of the hand-held ultrasound machine used by less experienced users will still need to be verified.
Overall Experimental Strategy and/or Methodology:
Different levels of IUS experience will be defined based on the time from the conclusion of the IBUS curriculum and the number of IUS exams performed per month:
Novice- up to one year after the conclusion of the IBUS curriculum. Performs at least 20 exams per month.
Intermediate experience- 1-2 years after the conclusion of the IBUS curriculum. Performs at least 20 exams per month. Total exams performed 500-1000 Experienced- >2 years after the conclusion of the IBUS curriculum. Performed> 1000 exams.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Crohn's patients undergoing routine intestinal ultrasound exam |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intestinal ultrasound | Diagnostic Test | Intestinal ultrasound performed by hand held ultrasound devices |
|
| Measure | Description | Time Frame |
|---|---|---|
| The capability and accuracy of hand-held ultrasound machines to detect bowel wall inflammatory activity and complications in CD patients. | Comparing various ultrasonographic signs of inflammation acquired by hand-held US machines to that acquired by high-end and premium US machines. Defining accuracy of hand-held ultrasound machines in the detection of bowel wall inflammatory activity | fro enrollmeent to the end of the study at 2 years |
Not provided
Not provided
Inclusion Criteria:
Crohn disease of the terminal ileum and colon- Age> 18
Exclusion Criteria:
Not provided
Not provided
Not provided
The study population will include 150 consecutive Crohn's patients going through intestinal ultrasound at the discretion of their referring physician.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dan Carter, Associate professor | Contact | +97235302197 | dan.carter@sheba.health.gov.il | |
| Adi Talan | Contact | +972544615875 | adi.talanasher@sheba.gov.il |
| Name | Affiliation | Role |
|---|---|---|
| Dan Carter, Associate Professor | Sheba Medical Center | Principal Investigator |
Not provided
IUS images - the data for he study- can not be shared due to patient privecy issure
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Nov 11, 2024 | Nov 11, 2024 | Prot_000.pdf |
Not provided
| ID | Term |
|---|---|
| D003424 | Crohn Disease |
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D007410 | Intestinal Diseases |